

Gail Tomlinson, M.D.
NOTE : If you're an existing patient of Dr. Tomlinson, please connect via MyChart
-
About Me
About Gail Tomlinson, M.D.
Dr. Tomlinson serves as the Division Chief of Pediatric Hematology-Oncology and currently also is the co-Director of the Population Science and Prevention Program at the Mays Cancer Center and part of the high-risk Genetic High-Risk Cancer Screening team. Since her arrival in 2007, she has also served as Interim Director of the GCCRI and Interim Chair of the Department of Pediatrics. She currently is the holder of the Greehey Distinguished Chair in Cancer and Genetics.
Dr. Tomlinson is board certified in pediatrics and pediatric hematology-oncology. Her clinical interests are in guiding individuals and families who may be at risk for cancer because of genetic predisposition and leads a multi-site program working with individuals and families throughout South Texas. Her research background is in the genetics and biology of liver tumors in children. She has recently initiated an investigation of predisposing factors underlying the increased incidence of leukemia in children of Hispanic background in South Texas and maintains a growing registry and biobank for children and adolescents with cancer. She has served on multiple national and state committees focusing on advancing research, education, and advocacy in childhood cancer and has published over 180 scientific papers. She currently is a member of the National Cancer Institute’s Board of Scientific Counselors.
Dr. Tomlinson received her M.D. from George Washington University School of Medicine and her Ph.D. in Biochemistry from Duke University. She completed an internship and residency at the Children’s National Medical Center in Washington, D.C. She did a research fellowship in cancer genetics at the University of Texas M.D. Anderson Cancer Center in Houston, followed by a formal fellowship in pediatric hematology-oncology at the University of Texas Southwestern Medical Center in Dallas. She was a faculty member at the University of Texas Southwestern Medical Center from 1992 to 2006, where she was a tenured Associate Professor and held the Children’s Cancer Fund Distinguished Professorship in Pediatric Oncology Research.
Gender
- Female
Languages Spoken
- English
-
Credentials
Credentials
Positions
- Professor of Pediatrics, University of Texas Health Science Center San Antonio
- Greehey Distinguished Chair in Cancer and Genetics
- Division Director, Pediatric Hematology-Oncology
- Co-Director, Population Science and Prevention Program
Certifications
- American Board of Pediatrics
- American Board of Pediatric Hematology-Oncology
Education
- Medical School: George Washington University School of Medicine, Washington, D.C.
- Residency: Children's Hospital National Medical Center, Washington, D.C.
- Fellowship: University of Texas Southwestern Medical Center, Dallas, TX
- Locations & Contact
-
Research & Publications
Research & Publications
No Research & Publications
-
Clinical Trials
Clinical Trials
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Gail Tomlinson M.D.
Genetics & Biology of Liver Tumorigenesis in Children
The overall goals of this Multi-Investigator Research Proposal is to further the understanding of the development and identify prognostic characteristics of liver tumors in children, particularly hepatoblastoma and its variants through a combined genomic and molecular pathology approach.
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Gail Tomlinson M.D.
Genetic Epidemiology of Breast and Ovarian Cancers
A research study about factors that might increase the chance of getting breast and ovarian cancers. Eligible: female 18-80 yr old; diagnosed with breast cancer under age 50; diagnosed with ovarian cancer at any age; strong family history of breast and/or ovarian cancer.
Type of Cancer
Germ Cell Tumors of the CNS
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Gail Tomlinson M.D.
Evaluating Utility and Improving Implementation of Genomic Sequencing for Pediatric Cancer Patients in the Diverse Population and Healthcare Setting in Texas: The KidsCanSeq Study (CTMS# 18-0152)
<p>The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.</p>
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Gail Tomlinson M.D.
Genomic characterization of hepatocellular carcinoma in children; comparison to adult tumors and identification of driver genes and pathways